Debby Bogaert

Dr. Debby Bogaert


Research Focus & Metrics

Academic Career Length

26Years (2001-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2004 in The Lancet Infectious Diseases
Verified
Journal Article
Closed access
DBDebby Bogaert
Debby Bogaert
RGR de Groot
R de Groot
PHPwm Hermans
Pwm Hermans

20 March 2017 in Nature Reviews Microbiology
Verified
Journal Article
Closed access
PDF file
WMWing Ho Man
Wing Ho Man
WPWouter A.A. de Steenhuijsen Piters
Wouter A.A. de Steenhuijsen Piters
DBDebby Bogaert
Debby Bogaert

10 January 2013 in PLOS Pathogens
Verified
Journal Article
Open access
PDF file
ABAstrid A. T. M. Bosch
Astrid A. T. M. Bosch
GBGiske Biesbroek
Giske Biesbroek
KTKrzysztof Trzcinski
Krzysztof Trzcinski
ESElisabeth A. M. Sanders
Elisabeth A. M. Sanders
DBDebby Bogaert
Debby Bogaert
Respiratory infectious diseases are mainly caused by viruses or bacteria that often interact with one another. Although their presence is a prerequisite for subsequent infections, viruses and bacteria may be present in the nasopharynx without causing any respiratory symptoms. The upper respiratory tract hosts a vast range of commensals and potential pathogenic bacteria, which form a complex microbial community. This community is assumed to be constantly subject to synergistic and competitive interspecies interactions. Disturbances in the equilibrium, for instance due to the acquisition of new bacteria or viruses, may lead to overgrowth and invasion. A better understanding of the dynamics between commensals and pathogens in the upper respiratory tract may provide better insight into the pathogenesis of respiratory diseases. Here we review the current knowledge regarding specific bacterial–bacterial and viral–bacterial interactions that occur in the upper respiratory niche, and discuss mechanisms by which these interactions might be mediated. Finally, we propose a theoretical model to summarize and illustrate these mechanisms.

1 December 2014 in American Journal of Respiratory and Critical Care Medicine
Verified
Journal Article
Closed access
GBGiske Biesbroek
Giske Biesbroek
ETEvgeni Tsivtsivadze
Evgeni Tsivtsivadze
ESElisabeth A. M. Sanders
Elisabeth A. M. Sanders
RMRoy Montijn
Roy Montijn
RVReinier H. Veenhoven
Reinier H. Veenhoven
DBDebby Bogaert
Debby Bogaert
Rationale: Many bacterial pathogens causing respiratory infections in children are common residents of the respiratory tract. Insight into bacterial colonization patterns and microbiota stability at a young age might elucidate healthy or susceptible conditions for development of respiratory disease. Objectives: To study bacterial succession of the respiratory microbiota in the first 2 years of life and its relation to respiratory health characteristics. Methods: Upper respiratory microbiota profiles of 60 healthy children at the ages of 1.5, 6, 12, and 24 months were characterized by 16S-based pyrosequencing. We determined consecutive microbiota profiles by machine-learning algorithms and validated the findings cross-sectionally in an additional cohort of 140 children per age group. Measurements and Main Results: Overall, we identified eight distinct microbiota profiles in the upper respiratory tract of healthy infants. Profiles could already be identified at 1.5 months of age and were associated with microbiota stability and change over the first 2 years of life. More stable patterns were marked by early presence and high abundance of Moraxella and Corynebacterium/Dolosigranulum and were positively associated with breastfeeding in the first period of life and with lower rates of parental-reported respiratory infections in the consecutive periods. Less stable profiles were marked by high abundance of Haemophilus or Streptococcus. Conclusions: These findings provide novel insights into microbial succession in the respiratory tract in infancy and link early-life profiles to microbiota stability and respiratory health characteristics. New prospective studies should elucidate potential implications of our findings for early diagnosis and prevention of respiratory infections. Clinical trial registered with www.clinicaltrials.gov (NCT00189020).

1 June 2004 in The Lancet
Verified
Journal Article
Closed access
DBDebby Bogaert
Debby Bogaert
ABA van Belkum
A van Belkum
MSM Sluijter
M Sluijter
ALA Luijendijk
A Luijendijk
RGR de Groot
R de Groot
PHPwm Hermans
Pwm Hermans

28 February 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
DBDebby Bogaert
Debby Bogaert
BKBart Keijser
Bart Keijser
SHSusan Huse
Susan Huse
JRJohn W.A. Rossen
John W.A. Rossen
RVReinier Veenhoven
Reinier Veenhoven
ESElisabeth Sanders
Elisabeth Sanders
The nasopharynx is the ecological niche for many commensal bacteria and for potential respiratory or invasive pathogens like Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitidis. Disturbance of a balanced nasopharyngeal (NP) microbiome might be involved in the onset of symptomatic infections with these pathogens, which occurs primarily in fall and winter. It is unknown whether seasonal infection patterns are associated with concomitant changes in NP microbiota. As young children are generally prone to respiratory and invasive infections, we characterized the NP microbiota of 96 healthy children by barcoded pyrosequencing of the V5–V6 hypervariable region of the 16S-rRNA gene, and compared microbiota composition between children sampled in winter/fall with children sampled in spring. The approximately 1000000 sequences generated represented 13 taxonomic phyla and approximately 250 species-level phyla types (OTUs). The 5 most predominant phyla were Proteobacteria (64%), Firmicutes (21%), Bacteroidetes (11%), Actinobacteria (3%) and Fusobacteria (1,4%) with Moraxella, Haemophilus, Streptococcus, Flavobacteria, Dolosigranulum, Corynebacterium and Neisseria as predominant genera. The inter-individual variability was that high that on OTU level a core microbiome could not be defined. Microbiota profiles varied strongly with season, with in fall/winter a predominance of Proteobacteria (relative abundance (% of all sequences): 75% versus 51% in spring) and Fusobacteria (absolute abundance (% of children): 14% versus 2% in spring), and in spring a predominance of Bacteroidetes (relative abundance: 19% versus 3% in fall/winter, absolute abundance: 91% versus 54% in fall/winter), and Firmicutes. The latter increase is mainly due to (Brevi)bacillus and Lactobacillus species (absolute abundance: 96% versus 10% in fall/winter) which are like Bacteroidetes species generally related to healthy ecosystems. The observed seasonal effects could not be attributed to recent antibiotics or viral co-infection. The NP microbiota of young children is highly diverse and appears different between seasons. These differences seem independent of antibiotic use or viral co-infection.